Ablynx
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
204 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
May 21, 2015 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| May 26, 2015 | Myriad Opportunities Master Fund Limited | 0.55% | June 11, 2015 |
| May 22, 2015 | Linden Advisors LP | 1.04% | May 27, 2015 |
| May 21, 2015 | Myriad Opportunities Master Fund Limited | 0.73% | May 26, 2015 |
| May 21, 2015 | Linden Advisors LP | 0.62% | May 22, 2015 |
Other companies sold short in Belgium
- Solvay 2.07% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- EVS 0.80% of the capital sold short
- Azelis 0.71% of the capital sold short
- Umicore 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- WDP 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Ablynx, source FSMA, data as at May 16, 2018, https://www.quivad.com/action/ablynx?page=5